Dyne Therapeutics
113 hedge funds and large institutions have $571M invested in Dyne Therapeutics in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less capital invested
Capital invested by funds: $573M → $571M (-$1.79M)
Holders
113
Holding in Top 10
3
Calls
$860K
Puts
$49K
Top Buyers
| 1 | +$26.9M | |
| 2 | +$10.8M | |
| 3 | +$5.81M | |
| 4 |
Goldman Sachs
New York
|
+$5.08M |
| 5 |
Axa
Paris,
France
|
+$4.27M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$5.79M | |
| 3 | -$2.24M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.59M |
| 5 |
Citigroup
New York
|
-$1.35M |